INDEPENDENT FACTORS FOR POOR PROGNOSIS IN YOUNG PATIENTS WITH STAGE I-III BREAST CANCER

被引:7
作者
Eric, Ivan [1 ,2 ]
Eric, Anamarija Petek [1 ,2 ]
Koprivcic, Ivan [1 ,2 ]
Babic, Marko [1 ,2 ]
Pacaric, Stana [2 ]
Trogrlic, Bojan [1 ,2 ]
机构
[1] Josip Juraj Strossmayer Univ Osijek, Fac Med, Osijek, Croatia
[2] Osijek Univ Hosp Ctr, Josipa Huttlera 4, HR-31000 Osijek, Croatia
关键词
Breast cancer; Young women; Multivariate analysis; Independent risk factor; 20-YEAR FOLLOW-UP; PATHOLOGICAL FEATURES; TUMOR SIZE; WOMEN; AGE; SURVIVAL; MASTECTOMY; CARCINOMA; NUMBER; NODES;
D O I
10.20471/acc.2020.59.02.07
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Breast cancer is the most common malignancy in the population of women under 40 years of age. Young age is an independent factor for poor prognosis. In this research, we tried to establish other factors for poor prognosis in stage I-III breast cancer. The following parameters were observed: tumor size, lymph node status, histologic grade, hormonal receptor status, Ki-67 prognostic index, Her2 neu status, histologic type of the tumor, local recurrence and metastases. Logistic regression was used to evaluate the effect of specific factors on the probability of lethal outcome and development of distant metastases. Our patients showed a predominance of T1 tumor (49.4%), had positive lymph nodes (62%) and most of them were pN1 (61.2%). Up to one-third of patients had triple negative status. Ki-67 proliferation index was high (25%). Multicentric tumor was detected in 23% of patients. There was no difference in overall survival between the two types of surgical procedures. Patients with pN0 status had better overall survival. Breast cancer in the population of young women has a more aggressive nature. Study results indicated positive lymph node status as an independent factor for poor prognosis of stage I-III breast cancer.
引用
收藏
页码:242 / 251
页数:10
相关论文
共 50 条
[41]   Tumor characteristics, therapy, and prognosis in young breast cancer patients=35 years [J].
Eckardt, Naaja-Kristin ;
Ignatov, Atanas ;
Meinecke, Anne-Marie ;
Burger, Elke ;
Costa, Serban-Dan ;
Eggemann, Holm .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (02) :709-719
[42]   Pegylated Liposomal Doxorubicin Versus Epirubicin as Adjuvant Therapy for Stage I-III Breast Cancer [J].
Hu, Wenxian ;
Lv, Kezhen ;
Teng, Rongyue ;
Chen, Jida ;
Xu, Chenpu ;
Jin, Lidan ;
Chen, Yongxia ;
Zhao, Wenhe .
FRONTIERS IN GENETICS, 2021, 12
[43]   Predictive factors for distant recurrence of colorectal cancer in patients after curative resection for stage I-III colorectal cancer in Australia [J].
Prabhakaran, Swetha ;
Kong, Joseph C. ;
Chin, Martin ;
Carne, Peter ;
Farmer, Chip ;
Skinner, Stewart ;
Warrier, Satish K. ;
Bell, Stephen .
LANGENBECKS ARCHIVES OF SURGERY, 2021, 406 (08) :2789-2796
[44]   Prognostic marker profile to assess risk in stage I-III hormone receptor-positive breast cancer patients [J].
Brerner, Troy M. ;
Jacquemier, Jocelyne ;
Charafe-Jauffret, Emmanuelle ;
Viens, Patrice ;
Birnbaum, Daniel ;
Linke, Steven P. .
INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (04) :896-904
[45]   The EORTC 22922/10925 trial investigating regional nodal irradiation in stage I-III breast cancer: Outcomes according to locoregional and systemic therapies [J].
Kaidar-Person, Orit ;
Boersma, Liesbeth J. ;
De Brouwer, Peter ;
Weltens, Caroline ;
Kirkove, Carine ;
Peignaux-Casasnovas, Karine ;
Budach, Volker ;
van der Leij, Femke ;
Peters, Max ;
Weidner, Nicola ;
Rivera, Sofia ;
van Tienhoven, Geertjan ;
Fourquet, Alain ;
Noel, Georges ;
Valli, Mariacarla ;
Guckenberger, Matthias ;
Koiter, Eveline ;
Racadot, Severine ;
Abdah-Bortnyak, Roxolyana ;
Bartelink, Harry ;
Struikmans, Henk ;
Fortpied, Catherine ;
Poortmans, Philip M. .
RADIOTHERAPY AND ONCOLOGY, 2024, 201
[46]   De novo post-diagnosis statin use, breast cancer-specific and overall mortality in women with stage I-III breast cancer [J].
Smith, Amelia ;
Murphy, Laura ;
Sharp, Linda ;
O'Connor, Darran ;
Gallagher, William M. ;
Bennett, Kathleen ;
Barron, Thomas I. .
BRITISH JOURNAL OF CANCER, 2016, 115 (05) :592-598
[47]   Prognostic Evaluation of Metastasis-Related Lymphocyte/Monocyte Ratio in Stage I-III Breast Cancer Receiving Chemotherapy [J].
Zhang, Zihan ;
Lin, Qian ;
Chen, Yi ;
Su, Chenlin ;
Lin, Wuye ;
Wei, Daoyu ;
Zhang, Litu ;
Liu, Haizhou .
FRONTIERS IN ONCOLOGY, 2022, 11
[48]   Effect of glucocorticoid use on survival in patients with stage I–III breast cancer [J].
Ching-Hung Lin ;
Po-Ya Chuang ;
San-Lin You ;
Chun-Ju Chiang ;
Chiun-Sheng Huang ;
Ming-Yang Wang ;
Ming Chao ;
Yen-Shen Lu ;
Ann-Lii Cheng ;
Chao-Hsiun Tang .
Breast Cancer Research and Treatment, 2018, 171 :225-234
[49]   Racial Disparities in Locoregional Recurrence in Postmenopausal Patients with Stage I-III, Hormone Receptor-Positive Breast Cancer Enrolled in the NSABP B-42 Clinical Trial [J].
Glass, Charity C. ;
Pride, Robert M. ;
Freedman, Rachel A. ;
Mayer, Erica L. ;
Ogayo, Esther R. ;
Chavez-MacGregor, Mariana ;
King, Tari A. ;
Mittendorf, Elizabeth A. ;
Kantor, Olga .
ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (13) :8320-8326
[50]   Dose coverage of axillary level I-III areas during whole breast irradiation with simplified intensity modulated radiation therapy in early stage breast cancer patients [J].
Zhang, Li ;
Yang, Zhao-zhi ;
Chen, Xing-xing ;
Tuan, Jeffrey ;
Ma, Jin-li ;
Mei, Xin ;
Yu, Xiao-li ;
Zhou, Zhi-rui ;
Shao, Zhi-min ;
Liu, Guang-yu ;
Guo, Xiao-mao .
ONCOTARGET, 2015, 6 (20) :18183-18191